1. Home
  2. SYM vs PTCT Comparison

SYM vs PTCT Comparison

Compare SYM & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Symbotic Inc.

SYM

Symbotic Inc.

SELL

Current Price

$38.69

Market Cap

5.3B

Sector

Industrials

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$59.31

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SYM
PTCT
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.5B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
SYM
PTCT
Price
$38.69
$59.31
Analyst Decision
Buy
Buy
Analyst Count
17
15
Target Price
$62.86
★ $100.33
AVG Volume (30 Days)
★ 1.5M
1.2M
Earning Date
11-23-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 264.48
EPS
0.12
★ 0.90
Revenue
★ $2,246,922,000.00
$264,734,000.00
Revenue This Year
$24.68
N/A
Revenue Next Year
$29.41
$9.47
P/E Ratio
$331.42
★ $67.73
Revenue Growth
25.65
★ 36.19
52 Week Low
$36.47
$58.80
52 Week High
$87.88
$90.87

Technical Indicators

Market Signals
Indicator
SYM
PTCT
Relative Strength Index (RSI) 40.10 34.70
Support Level N/A N/A
Resistance Level $44.66 $68.93
Average True Range (ATR) 1.77 1.93
MACD -0.53 -0.15
Stochastic Oscillator 28.67 13.82

Price Performance

Historical Comparison
SYM
PTCT

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: